ConductScience.org, home

Paper26933263

Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.

Wang SL and 2 others. Can Vet J, 2016. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma. Papers, record 26933263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26933263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
PubMed
Journal
Can Vet J
PubMed
Year
2016
PubMed
Publication types
Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.24
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang SLShang-Lin
2Lee JJJih-Jong
3Liao ATAlbert Taiching

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Dog DiseasesMajor topic
DoxorubicinMajor topic
LymphomaMajor topic
MitoxantroneMajor topic
Animals
Cyclophosphamide
Dogs
Female
Male
Prednisone
Prospective Studies
Vincristine

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112465768Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma.J Vet Intern Med2002https://conductscience.org/library/papers/12465768PubMed
219379294Veterinary Co-operative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0.Vet Comp Oncol2004https://conductscience.org/library/papers/19379294PubMed
37744644Prognostic factors for treatment of malignant lymphoma in dogs.J Am Vet Med Assoc1994https://conductscience.org/library/papers/7744644PubMed
48077132Evaluation of mitoxantrone for the treatment of lymphoma in dogs.J Am Vet Med Assoc1994https://conductscience.org/library/papers/8077132PubMed
51277204Delayed and progressive myocardial lesions after adriamycin administration in the rabbit.Cancer Res1976https://conductscience.org/library/papers/1277204PubMed
63333887Canine lymphoma: clinical considerations.Semin Vet Med Surg Small Anim1986https://conductscience.org/library/papers/3333887PubMed
77879983Comparison of body surface area-based and weight-based dosage protocols for doxorubicin administration in dogs.Am J Vet Res1994https://conductscience.org/library/papers/7879983PubMed
820230579Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document.Vet Comp Oncol2010https://conductscience.org/library/papers/20230579PubMed
95538360The epidemiology of canine leukemia and lymphoma.Bibl Haematol1970https://conductscience.org/library/papers/5538360PubMed
1011467592Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.J Vet Intern Med2001https://conductscience.org/library/papers/11467592PubMed
118823340Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.J Clin Oncol1996https://conductscience.org/library/papers/8823340PubMed
1220445802Hormonal and sex impact on the epidemiology of canine lymphoma.J Cancer Epidemiol2009https://conductscience.org/library/papers/20445802PubMed
137083217Safety assessment of new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. II. Histologic and ultrastructural pathology.Cancer Treat Rep1982https://conductscience.org/library/papers/7083217PubMed
1420230577Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.Vet Comp Oncol2010https://conductscience.org/library/papers/20230577PubMed
1518289305Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs.J Vet Intern Med2008https://conductscience.org/library/papers/18289305PubMed
161588546Doxorubicin-induced cardiotoxicosis. Clinical features in 32 dogs.J Vet Intern Med1992https://conductscience.org/library/papers/1588546PubMed
1714197830GENETIC ASPECTS OF CARDIOVASCULAR DISEASES IN ANIMALS.Circulation1964https://conductscience.org/library/papers/14197830PubMed
18657163Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice.Cancer Treat Rep1978https://conductscience.org/library/papers/657163PubMed
192568172Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression.Cancer Res1989https://conductscience.org/library/papers/2568172PubMed
2020492493Monitoring of minimal residual disease (MRD) after multidrug chemotherapy and its correlation to outcome in dogs with lymphoma: a proof-of-concept pilot study.J Vet Intern Med2010https://conductscience.org/library/papers/20492493PubMed

See all 29 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
40443182
Comparison of outcomes in feline intermediate- to large-cell lymphoma treated with CMOP (cyclophosphamide, mitoxantrone, vincristine and prednisolone) instead of CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone).
J Feline Med Surg2025https://conductscience.org/library/papers/40443182PubMed
39902544Two GnRH-mitoxantrone Conjugates, Con-3 and Con-7, Target Endometrial Cancer CellsCurr Mol Pharmacol2024https://conductscience.org/library/papers/39902544PubMed
39274973Cytotoxic Activity of Novel GnRH Analogs Conjugated with Mitoxantrone in Ovarian Cancer Cells.Molecules2024https://conductscience.org/library/papers/39274973PubMed
38647264Evaluation of a multiagent chemotherapy protocol combining vincristine, cyclophosphamide, mitoxantrone and prednisolone (CMOP) for treatment of feline intermediate-large cell lymphoma.J Feline Med Surg2024https://conductscience.org/library/papers/38647264PubMed
37249647Fusion protein and hemagglutinin of canine distemper virus co-induce apoptosis in canine mammary tumor cells.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/37249647PubMed
37235425Review of Canine Lymphoma Treated with Chemotherapy-Outcomes and Prognostic Factors.Vet Sci2023https://conductscience.org/library/papers/37235425PubMed
35307756Interceptor potential of C60 fullerene aqueous solution: a comparative analysis using the example of the antitumor antibiotic mitoxantrone.Eur Biophys J2022https://conductscience.org/library/papers/35307756PubMed
34825413Toxicity, outcome, and management of anthracycline overdoses in 16 dogs.J Vet Intern Med2022https://conductscience.org/library/papers/34825413PubMed
33898277Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines.Open Vet J2021https://conductscience.org/library/papers/33898277PubMed
31812160Antiviral activity of mitoxantrone dihydrochloride against human herpes simplex virus mediated by suppression of the viral immediate early genes.BMC Microbiol2019https://conductscience.org/library/papers/31812160PubMed
30373251Oncolytic Viruses for Canine Cancer Treatment.Cancers (Basel)2018https://conductscience.org/library/papers/30373251PubMed
30209630Influence of Carbon Nanotubes and Its Derivatives on Tumor Cells In Vitro and Biochemical Parameters, Cellular Blood Composition In Vivo.Nanoscale Res Lett2018https://conductscience.org/library/papers/30209630PubMed
28272340Factors Which Influence Owners When Deciding to Use Chemotherapy in Terminally Ill Pets.Animals (Basel)2017https://conductscience.org/library/papers/28272340PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26933263

GET https://conductscience.org/api/papers/v1/26933263/references?page=2